- Generic name
- Palonosetron
- Strength
- .5 mg
- Dosage form
- Tablet
- Manufactured by
- Radiant Pharmaceuticals Ltd.
Oxipal 0.5 mg Tablet
About Oxipal 0.5 mg Tablet
The tablet Oxipal 0.5 mg contains Palonosetron and is made by Radiant Pharmaceuticals Ltd. It may be used for radiotherapy-related nausea as well.
There are 16 brands of Palonosetron listed in Bangladesh.
What is Oxipal 0.5 mg Tablet?
Oxipal 0.5 mg.5 mg tablet is a medicine made by Radiant Pharmaceuticals Ltd. Palonosetron works by blocking serotonin, a natural substance in the body that can set off the vomiting reflex. It works by blocking certain receptors involved in the vomiting reflex. Ask your doctor or pharmacist if you are unsure about it.
Uses of Oxipal 0.5 mg
It may be used for radiotherapy-related nausea as well. Only a healthcare professional can decide if it is suitable. It may also be used for nausea and vomiting after surgery. Ask your doctor whether it is right for your condition.
How to use Oxipal 0.5 mg
If you are unsure how or when to take it, ask your doctor or pharmacist. Swallow the tablet with water. Oxipal 0.5 mg is taken by mouth. Do not attempt to inject it yourself. The doctor decides the dose, when to take it and how long the course should last. Do not change the dose or stop on your own.
Side effects of Oxipal 0.5 mg
Do not self-treat side effects without advice. Your healthcare team can advise on what to do and whether any further care is needed. Do not try to treat side effects yourself without asking a healthcare professional first. Tell your doctor or nurse if you notice any side effect after the tablet, or if you have any concerns about how you feel. Tell your doctor if these bother you or do not settle.
Safety and precautions
Do not take Oxipal 0.5 mg if you have had an allergic reaction to Palonosetron or to any of the ingredients in the tablet. People with other health conditions should check with the doctor first. If you are pregnant, think you may be pregnant, or are breastfeeding, ask your doctor before taking it, because it is not known whether it passes into breast milk. The doctor will decide if it is suitable for you.
Frequently asked questions
What does Oxipal 0.5 mg treat?
It may be used for radiotherapy-related nausea as well. Only a healthcare professional can decide if it is suitable.
How is Oxipal 0.5 mg used?
If you are unsure how or when to take it, ask your doctor or pharmacist. Swallow the tablet with water.
What should I watch for while using Oxipal 0.5 mg?
Do not self-treat side effects without advice. Your healthcare team can advise on what to do and whether any further care is needed.
Who should be careful with Oxipal 0.5 mg?
Do not take Oxipal 0.5 mg if you have had an allergic reaction to Palonosetron or to any of the ingredients in the tablet. People with other health conditions should check with the doctor first.
Indications
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy ... Read more
- Acute and delayed nausea and vomiting
- Uncontrolled nausea and vomiting
- Chemotherapy-induced nausea and vomiting (CINV): Acute CINV resulting in on the day of treatment with certain types of chemotherapy
- Delayed CINV resulting in on days later with certain types of chemotherapy
- Radiotherapy-induced nausea and vomiting (RINV)
- Post-operative & Post-discharge nausea and vomiting (PONV & PDNV).
Pharmacology
Pharmacokinetics: Palonosetron exhibits linear dose-proportional pharmacokinetics over the doserange 1-90 pg/kg in healthy subjects and in patients with cancer. In cancer patients receiving single intravenous doses of Palonosetron in this dose range, the mean maximum plasma concentration (Cmax) ranges from 0.89 to 336 ng/ml and the area under the plasma concentration-time curve from zero to infinity (AUCo-co) ranges from 13.8 to 957 ng.h/ml. Palonosetron has a volume of distribution of approximately 6.9-7.9 L/kg, with approximately 62% bound to plasma proteins. Approximately 50% of Palonosetron is metabolized into two inactive metabolites that exhibit <1% of the 5-HT3 receptor antagonist activity. Approximately 40% of the drug is metabolised via kidney, 50% by liver CYP2D6 (mainly), CYP3A4 and CYP1A2 isoenzymes. About 50% of the drug goes under metabolism. After a single intravenous dose, approximately 40% is excreted as unchanged drug in the urine after 144 hours. Total body clearance of Palonosetron is 160±35 ml/h/kg, and renal clearance is 66.5±18.2 ml/h/kg in healthy subjects. Palonosetron exhibits a longer half-life (40 hours) and has a greater 5-HT3 receptor binding affinity.
Dosage & Administration
Chemotherapy-induced nausea and vomiting: Adult tablet dosage: 0.5 mg administered approximately 1 hour prior to the start of chemotherapy. Adult IV dosage: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before the start of chemotherapy.
Radiotherapy-induced nausea and vomiting: A single IV dose of 0.25 mg should be administered over 30 seconds approximately 30 minutes before each week of radiation fraction.
Post-operative nausea and vomiting: A single IV dose of 0.075 mg should be administered over 10 seconds immediately before induction of anesthesia.
Children dosage: (1 month to 17 years): A single IV dose at 20 mcg/kg body weight. Which maximum dose is 1.5 mg.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Overdose Effects
Storage Conditions
Alternative brands of Palonosetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.